Cited by 79Obsessive-Compulsive Spectrum DisordersSchizophrenia research and treatmentAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms?

Sareen, Jitender, Kirshner, Alla, Lander, Mark, Kjernisted, Kevin D., Eleff, Michael K., Reiss, Jeffrey P.·2004·Journal of Affective Disorders

Abstract

Background Paradoxically, some reports in the literature support the use of antipsychotics in the treatment of Obsessive Compulsive Disorder (OCD), while other reports suggest that antipsychotics can exacerbate OCD symptoms. To date, there is no published systematic review of the relationship between OCD symptoms and antipsychotic drugs. Methods A Medline and PsychInfo search (1980-2003) was conducted to collect published reports of the interactions between antipsychotics and OCD symptoms. Results In the treatment of refractory OCD, case series, open label trials and placebo-controlled trials were found suggesting efficacy of antipsychotic augmentation to ongoing antidepressant treatment. In the placebo-controlled trials with haloperidol, risperidone, olanzapine, and quetiapine, a significantly higher response rate (46-71%) was found for the antipsychotic groups, compared to no response for the placebo groups. Reports of exacerbation of OCD symptoms with the use of atypical antipsychotics were limited to individuals with a primary psychotic disorder. Limitations Definition of response in most of these treatment studies was based on a modest reduction of OCD symptoms, and no studies were available on long-term efficacy. There were also no published reports that systematically evaluated the incidence of OCD symptoms associated with atypical antipsychotics. Conclusions All antipsychotics mentioned above had short-term controlled evidence to support their use as augmenting agents…

Integrity signals

Registry

Crossref · 10.1016/j.jad.2004.03.011

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In OCD patients unresponsive to adequate SRI treatment, low-dose antipsychotic agents are sometimes added as an adjunct to SRIs.

    “In cases where OCD patients are unresponsive to such treatment, given for an adequate duration and at an adequate dose, low‐dose antipsychotic agents are sometimes added as an adjunct to SRIs”

    From Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction (2023) · cites this paper as Sareen et al., 2004

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 46 · Cited by 79

Authors
Sareen, J., Kirshner, A., Lander, M., Kjernisted, K. D., Eleff, M. K., & Reiss, J. P.
Affiliations
University of Manitoba (CA)
Corresponding author
Sareen, Jitender
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2004-10
Volume
82
Issue
2
Pages
167-174
ISSN
0165-0327 (ISSN-L)
OpenAlex
W106078291
Cited by
79
References
46
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 6 · 2013: 5
FWCI
1.30
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Manitoba Health Research Council
  • Winnipeg Foundation
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
obsessive-compulsive disorder, antipsychotic drugs, atypical antipsychotics, treatment-resistant OCD, augmentation therapy, haloperidol, risperidone, olanzapine, quetiapine, symptom exacerbation, selective serotonin reuptake inhibitors
MeSH terms
Antidepressive Agents, Dose-Response Relationship, Drug, Drug Therapy, Combination, Humans, Obsessive-Compulsive Disorder, Antipsychotic Agents, Selective Serotonin Reuptake Inhibitors, Disease Progression, Controlled Clinical Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review